"
Team:Carnegie Mellon
From 2012.igem.org
(Difference between revisions)
JSalazar88 (Talk | contribs) |
JSalazar88 (Talk | contribs) |
||
| Line 430: | Line 430: | ||
<li class="toclevel-1"><a href="#Introduction:_Motivation"><span class="tocnumber">1</span> <span class="toctext">Introduction: Motivation</span></a></li> | <li class="toclevel-1"><a href="#Introduction:_Motivation"><span class="tocnumber">1</span> <span class="toctext">Introduction: Motivation</span></a></li> | ||
<li class="toclevel-1"><a href="#Primary_Objective:_A_Useful_BioBrick_for_Synthetic_Biologists"><span class="tocnumber">2</span> <span class="toctext">Primary Objective: A Useful BioBrick for Synthetic Biologists</span></a></li> | <li class="toclevel-1"><a href="#Primary_Objective:_A_Useful_BioBrick_for_Synthetic_Biologists"><span class="tocnumber">2</span> <span class="toctext">Primary Objective: A Useful BioBrick for Synthetic Biologists</span></a></li> | ||
| - | <li class="toclevel-1"><a href="#Secondary_Objective: | + | <li class="toclevel-1"><a href="#Secondary_Objective:_Humanistic_Practice"><span class="tocnumber">3</span> <span class="toctext">Secondary Objective: Humanistic Practice</span></a></li> |
<li class="toclevel-1"><a href="#Further_Considerations"><span class="tocnumber">4</span> <span class="toctext">Further Considerations</span></a></li> | <li class="toclevel-1"><a href="#Further_Considerations"><span class="tocnumber">4</span> <span class="toctext">Further Considerations</span></a></li> | ||
</ul> | </ul> | ||
| Line 458: | Line 458: | ||
<p>Our proposed BioBrick is novel, and potentially very useful in practice. | <p>Our proposed BioBrick is novel, and potentially very useful in practice. | ||
</p> | </p> | ||
| - | <a name="Secondary_Objective: | + | <a name="Secondary_Objective:_Humanistic_Practice"></a><h2> <span class="mw-headline"> Secondary Objective: Humanistic Practice</span></h2> |
| - | <p> | + | <p> <a href="https://2012.igem.org/Team:Carnegie_Mellon" class="external text" title="https://2012.igem.org/Team:Carnegie_Mellon" rel="nofollow">our 2012 team</a> in engineering <i>Escherichia coli</i> to <b>be awesome</b>. Here is a link to awesomeness (<a href="http://www.who.int/nutrition/topics/vad/en/" class="external text" title="http://www.who.int/nutrition/topics/vad/en/" rel="nofollow">WHO</a>). |
</p> | </p> | ||
<a name="Further_Considerations"></a><h2> <span class="mw-headline"> Further Considerations </span></h2> | <a name="Further_Considerations"></a><h2> <span class="mw-headline"> Further Considerations </span></h2> | ||
Revision as of 11:35, 11 June 2012
Team:Carnegie_Mellon
From 2012.igem.org
Contents |
Introduction: Motivation
- We seek to develop a BioBrick that will allow researchers in the field of synthetic biology to accurately measure translational efficiency, and transcriptional strength.
- We believe that we can use Spinach as a biosensor to reflect these metrics in vivo, rather than in vitro, which has previously proven to be very costly and impractical.
- We will characterize the relationship between genetic expression of Spinach (upstream), translational efficiency, and transcriptional strength.
Abstract/Introduction
Motivation question
Humanistic implications go here
Primary Objective: A Useful BioBrick for Synthetic Biologists
We believe the development of this unprecedented BioBrick will help synthetic biologists in a variety of applications, for a variety of purposes such as the following:
- example application
- example application
- example application
Our proposed BioBrick is novel, and potentially very useful in practice.
Secondary Objective: Humanistic Practice
our 2012 team in engineering Escherichia coli to be awesome. Here is a link to awesomeness (WHO).
Further Considerations
In the pursuit of our project, as well as the biological aspects, we:
- considered aspects of scale-up, including the ethical, legal and social implications of our potential final product, MicroMaize,
- programmed a new piece of software for use in metabolic modelling,
- developed and tested techniques for measuring translational efficiency and transcriptional strength,
- participated in human practices demonstration xxx.
